Sarasota Medical Technologies Inc Bradenton, FL - 34201

Sarasota Medical Technologies Inc is categorized under Health Services in Bradenton, FL and active since 2010.

Sarasota Medical Technologies Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.

If you are seeking more information, feel free to contact John Zyznomyrsky at the company’s single location by writing to 6172 Palomino Circle, Bradenton, Florida FL 34201 or by phoning (941) 351-9639. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Sarasota Medical Technologies Inc
Contact Person: John Zyznomyrsky
Address: 6172 Palomino Circle, Bradenton, Florida 34201
Phone Number: (941) 351-9639
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 621999
Share This Business:

Sarasota Medical Technologies Inc was started in 2010 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact John Zyznomyrsky for inquiries that concern Sarasota Medical Technologies Inc by calling the company number (941) 351-9639, as your correspondence is most welcome. Additionally, the physical location of the single location of Sarasota Medical Technologies Inc can be found at the coordinates 27.424986,-82.483164 as well as the street address 6172 Palomino Circle in Bradenton, Florida 34201.

For its online presence, you may visit Sarasota Medical Technologies Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.